REFERENCES
1. Mottet N, van den Bergh RCN, Briers E, et al. EAU - ESTRO -
ESUR - SIOG Guidelines on Prostate Cancer 2020. European
Association of Urology Guidelines. 2020 Edition. Vol presented at the
EAU Annual Congress Amsterdam 2020. Arnhem, The Netherlands: European
Association of Urology Guidelines Office; 2020.
2. Katims AB, Razdan S, Eilender BM, et al. Urologic oncology
practice during COVID-19 pandemic: A systematic review on what can be
deferrable vs. nondeferrable. Urologic Oncology: Seminars and
Original Investigations : Elsevier; 2020.
3. Boorjian SA, Bianco Jr FJ, Scardino PT, Eastham JA. Does the
time from biopsy to surgery affect biochemical recurrence after radical
prostatectomy? BJU international. 2005;96:773-776.
4. Çelik S, Tınay İ, Narter F, et al. Management of Patients
with Urological Cancers in Turkey during the COVID-19 Pandemic:
Recommendations of Uro-oncology Association. Bull Urooncol.2020;19:100-103.
5. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde
JG. Research electronic data capture (REDCap)—a metadata-driven
methodology and workflow process for providing translational research
informatics support. Journal of biomedical informatics.2009;42:377-381.
6. RT PH, Minor B, Elliott V. REDCap Consortium, the REDCap
Consortium: building an international community of software partners.J Biomed Inform. 2019.
7. Davidson-Pilon C, Kalderstam J, Jacobson N, et al.
CamDavidsonPilon/lifelines: v0. 25.4. Zenodo: Genève,
Switzerland. 2020.
8. Deka R, Courtney PT, Parsons JK, et al. Association Between
African American Race and Clinical Outcomes in Men Treated for Low-Risk
Prostate Cancer With Active Surveillance. JAMA.2020;324:1747-1754.
9. Richard PO, Timilshina N, Komisarenko M, et al. The
long-term outcomes of Gleason grade groups 2 and 3 prostate cancer
managed by active surveillance: Results from a large population-based
cohort. Canadian Urological Association Journal. 2020;14.
10. Zanaty M, Alnazari M, Ajib K, et al. Does surgical delay
for radical prostatectomy affect biochemical recurrence? A retrospective
analysis from a Canadian cohort. World journal of urology.2018;36:1-6.
11. Gupta N, Bivalacqua TJ, Han M, et al. Evaluating the impact
of length of time from diagnosis to surgery in patients with
unfavourable intermediate‐risk to very‐high‐risk clinically localised
prostate cancer. BJU international. 2019;124:268-274.
12. Neal RD, Tharmanathan P, France B, et al. Is increased time
to diagnosis and treatment in symptomatic cancer associated with poorer
outcomes? Systematic review. British Journal of Cancer.2015;112:S92-S107.
13. Hollenbeck BK, Dunn RL, Ye Z, et al. Delays in diagnosis
and bladder cancer mortality. Cancer. 2010;116:5235-5242.
14. Wallace D, Bryan R, Dunn J, Begum G, Bathers S, Group WMUR.
Delay and survival in bladder cancer. BJU international.2002;89:868-878.
15. Akdas A, Kirkah Z, Remzi D. The Role of Delay in Stage-Ill
Testicular Tumors. European urology. 1986;12:151-153.
16. Huyghe E, Muller A, Mieusset R, et al. Impact of diagnostic
delay in testis cancer: results of a large population-based study.European urology. 2007;52:1710-1716.
17. Dieckmann K-P, Becker T, Bauer H. Testicular tumors:
presentation and role of diagnostic delay. Urologia
internationalis. 1987;42:241-247.
18. Meffan P, Delahunt B, Nacey J. The value of early diagnosis
in the treatment of patients with testicular cancer. The New
Zealand Medical Journal. 1991;104:393-394.
19. Laguna MP, Albers P, Algaba F, et al. EAU Guidelines on
Testicular Cancer 2020. European Association of Urology
Guidelines. 2020 Edition. Vol presented at the EAU Annual Congress
Amsterdam 2020. Arnhem, The Netherlands: European Association of Urology
Guidelines Office; 2020.
20. Volpe A, Cadeddu JA, Cestari A, et al. Contemporary
management of small renal masses. European urology.2011;60:501-515.
21. Van Poppel H, Joniau S. Is surveillance an option for the
treatment of small renal masses? European urology.2007;52:1323-1330.
22. Bourgade V, Drouin SJ, Yates DR, et al. Impact of the
length of time between diagnosis and surgical removal of urologic
neoplasms on survival. World journal of urology. 2014;32:475-479.
23. Zanaty M, Alnazari M, Lawson K, et al. Does surgical delay
for radical prostatectomy affect patient pathological outcome? A
retrospective analysis from a Canadian cohort. Canadian Urological
Association Journal. 2017;11:265.
24. Morini MA, Muller RL, de Castro Junior PCB, de Souza RJ,
Faria EF. Time between diagnosis and surgical treatment on pathological
and clinical outcomes in prostate cancer: does it matter? World
journal of urology. 2018;36:1225-1231.
25. Korets R, Seager CM, Pitman MS, Hruby GW, Benson MC,
McKiernan JM. Effect of delaying surgery on radical prostatectomy
outcomes: a contemporary analysis. BJU international.2012;110:211-216.
26. Redaniel MT, Martin RM, Gillatt D, Wade J, Jeffreys M. Time
from diagnosis to surgery and prostate cancer survival: a retrospective
cohort study. BMC cancer. 2013;13:559.
27. Khan MA, Mangold LA, Epstein JI, Boitnott JK, Walsh PC,
Partin AW. Impact of surgical delay on long-term cancer control for
clinically localized prostate cancer. The Journal of urology.2004;172:1835-1839.
28. O’Brien D, Loeb S, Carvalhal GF, et al. Delay of surgery in
men with low risk prostate cancer. The Journal of urology.2011;185:2143-2147.